Pfizer Beefs Up Blood Cancer Pipeline With Trillium Acquisition: See Highlights
BeiGene's Brukinsa Prolongs Progression-Free Survival Compared To Chemo In Untreated Blood Cancer Patients
Magenta Therapeutics Stock Drops As FDA Issues Clinical Hold On Blood Cancer Candidate IND
Caribou Biosciences Eyes $100M NASDAQ Debut To Propel Off-The-Shelf CAR-T Therapies In Blood Cancer
Blood Cancer Recent News
Precision BioSciences Starts Dosing In Blood Cancer Trial With CAR T Therapy
Jazz Pharma's Rylaze Scores FDA Approval For Blood Cancer
Salarius Pharmaceuticals Launches Mid-Stage Blood Cancer Trial With Seclidemstat
Protagonist Stock Moves Higher As Rusfertide Shows Durability Of Effect, Symptom Improvements In Blood Cancer Trial
Curis Shares Drop After Updated CA-4948 Data From Mid-Stage Blood Cancer Trial
Allogene's Stock Jumps After Blood Cancer Candidates Show Durable Response
BeiGene's Brukinsa On Par With JNJ's Imbruvica In Late-Stage Blood Cancer Studies
Humanigen's Lenzilumab Shows Encouraging Response Rate In Blood Cancer Study
Karyopharm's Selinexor Receives Conditional Approval In Europe For Type Of Blood Cancer
Bluebird bio Says Lentiviral Vector Not the Cause Of Blood Cancer Reported In Sickle Cell Study
Innate Pharma To Test Lacutamab In Relapsed/Refractory Peripheral T-Cell Lymphoma Patients